Differential efficacy of nicotine replacement among overweight and obese women smokers

Nicotine and Tobacco Research

Volumn 17, Issue 7, 2015, Pages 855-861

  Strong, David R ^a   David, Sean P ^b   Johnstone, Elaine C ^c   Aveyard, Paul ^c   Murphy, Michael F ^d   Munafò, Marcus R ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH; PLACEBO; NICOTINE; NICOTINE GUM;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OBESITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; WOMEN'S HEALTH; CUTANEOUS DRUG ADMINISTRATION; FOLLOW UP; MIDDLE AGED; OVERWEIGHT; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINE; OBESITY; OVERWEIGHT; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME;

EID: 84937033341     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu256     Document Type: Article

References (32)

1. World Health Organization. WHO Report on the Global Epidemic, 2013: Enforcing Bans on Tobacco Advertising, Promotion, Sponsorship. Geneva, Switzerland: WHO Press; 2013.
2. Freedman DM, Sigurdson AJ, Rajaraman P, Doody MM, Linet MS, Ron E. The mortality risk of smoking and obesity combined. Am J Prev Med. 2006;31:355-362.
3. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998;97:2099-2100.
4. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood). 2002;21:245-253.
5. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801-809.
6. Bush T, Levine MD, Deprey M, et al. Prevalence of weight concerns and obesity among smokers calling a quitline. J Smok Cessat. 2008;4:74-78.
7. Siahpush M, Singh GK, Tibbits M, Pinard CA, Shaikh RA, Yaroch A. It is better to be a fat ex-smoker than a thin smoker: findings from the 1997-2004 National Health Interview Survey-National Death Index linkage study. Tob Control. 2013;23:395-402. doi:10.1136/tobaccocontrol-2012-050912.
8. Kotz D, Fidler J, West R. Factors associated with the use of aids to cessation in English smokers. Addiction. 2009;104:1403-1410.
9. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. Drug Alcohol Depend. 2008;93:121-131.
10. Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav. 2009;92:6-11.
11. Liu T, David SP, Tyndale RF, et al. Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers. Ann Behav Med. 2012;43:253-261.
12. Mineur YS, Abizaid A, Rao Y, et al. Nicotine decreases food intake through activation of POMC neurons. Science. 2011;332:1330-1332.
13. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555-560.
14. Piper ME, Schlam TR, Cook JW, et al. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl). 2011;216:569-578.
15. Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MA. Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berl). 1992;106:421-427.
16. Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol. 2006;74:1153-1161.
17. Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG. Reduction of abstinence-induced withdrawal and craving using highdose nicotine replacement therapy. Psychopharmacology (Berl). 2006;184:637-644.
18. Lerman C, Audrain J, Patterson F, et al. Differential response to nicotine replacement therapies in obese and non-obese smokers. Paper presented at: the Society for Research on Nicotine and Tobacco Annual Meeting; February 2003; New Orleans, LA.
19. Chen LS, Bloom AJ, Baker TB, et al. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction. 2014;109:128-137.
20. Prather RD, Tu TG, Rolf CN, Gorsline J. Nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) in women and obese men compared with normal-sized men. J Clin Pharmacol. 1993;33:644-649.
21. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Brit Med J. 1993;306: 1304-1308.
22. Aveyard P, Brown K, Saunders C, et al. Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax. 2007;62:898-903.
23. Russell MA, Peto J, Patel UA. The classification of smoking by factorial structure of motives. J Roy Stat Soc A (General). 1974;137:313-333.
24. Harrell FE. Regression Modeling Strategies. R package version 3.6-2. 2012. http://CRAN.R-project.org/package=rms.
25. Bates D, Maechler M, Bolker B, Walker S. lme4: Linear Mixed-Effects Models Using Eigen and S4. R package version 1.0-6. 2014.
26. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York, NY: Springer; 2009.
27. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;CD000146. doi: 10.1002/14651858.CD000146.pub3.
28. Perkins KA, Gerlach D, Vender J, Grobe J, Meeker J, Hutchison S. Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob Res. 2001;3:141-150.
29. Zoli M, Picciotto MR. Nicotinic regulation of energy homeostasis. Nicotine Tob Res. 2012;14:1270-1290.
30. Levine MD, Perkins KA, Marcus MD. The characteristics of women smokers concerned about postcessation weight gain. Addict Behav. 2001;26:749-756.
31. Swan GE, Javitz HS, Jack LM, Curry SJ, McAfee T. Heterogeneity in 12-month outcome among female and male smokers. Addiction. 2004;99:237-250.
32. Bush TM, Levine MD, Magnusson B, et al. Impact of baseline weight on smoking cessation and weight gain in quitlines. Ann Behav Med. 2014;47:208-217.